dc.contributor.author |
Lipp, Hans-Peter |
|
dc.date.accessioned |
2020-06-16T11:06:41Z |
|
dc.date.available |
2020-06-16T11:06:41Z |
|
dc.date.issued |
2019 |
|
dc.identifier.issn |
1473-4877 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/101501 |
|
dc.language.iso |
en |
en |
dc.publisher |
Taylor & Francis Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1080/03007995.2018.1545635 |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
A new formulation of levothyroxine engineered to meet new specification standards |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20190926111821_03055 |
|
utue.publikation.seiten |
147-150 |
de_DE |
utue.personen.roh |
Lipp, Hans-Peter |
|
utue.personen.roh |
Hostalek, Ulrike |
|
dcterms.isPartOf.ZSTitelID |
Current Medical Research and Opinion |
de_DE |
dcterms.isPartOf.ZS-Issue |
1 |
de_DE |
dcterms.isPartOf.ZS-Volume |
35 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
|